[1]
|
E. J. Artsa and S. F. Le Grice, “Interaction of Retroviral Reverse Transcriptase with Template-Primer Duplexes during Replication,” Progress in Nucleic Acid Research and Molecular Biology, Vol. 58, 1997, pp. 339-393.
doi:10.1016/S0079-6603(08)60041-0
|
[2]
|
V. Goldschmidt, J. Didierjean, B. Ehresmann, et al., “Mg2+ Dependency of HIV-1 Reverse Transcription, In-hibition by Nucleoside Analogues and Resistance,” Nucleic Acids Research, Vol. 34, No. 1, 2006, pp. 42-52.
doi:10.1093/nar/gkj411
|
[3]
|
M. G?tte, “Inhibition of HIV-1 Reverse Transcription: Basic Principles of Drug Action and Resistance,” Expert Review of Anti-Infective Therapy, Vol. 2, 2004, pp. 707-716. doi:10.1586/14789072.2.5.707
|
[4]
|
M. G?tte, S. Fackler, T. Hermann, et al., “HIV-1 Reverse Transcriptase-Associated Rnase H Cleaves RNA/RNA in Arrested Complexes: Implications for the Mechanism by Which Rnase H Discriminates between RNA/RNA and RNA/DNA,” EMBO Journal, Vol. 14, No. 4, 1995, pp. 833-841.
|
[5]
|
S. J. Schultz and J. J. Champoux, “RNase H Activity: Structure, Specificity, and Function in Reverse Transcrip-tion,” Virus Research, Vol. 134, No. 1-2, 2008, pp. 86-103. doi:10.1016/j.virusres.2007.12.007
|
[6]
|
M. Nowotny and W. Yang, “Stepwise Analyses of Metal Ions in Rnase H Catalysis from Substrate Destabilization to Product Release,” EMBO Journal, Vol. 25, No. 9, 2006, pp. 1924-1933. doi:10.1038/sj.emboj.7601076
|
[7]
|
W. Yang, J. Y. Lee and M. Nowotny, “Making and Breaking Nucleic Acids: Two-Mg2+-Ion Catalysis and Substrate Specificity,” Molecular Cell, Vol. 22, No. 1, 2006, pp. 5-13. doi:10.1016/j.molcel.2006.03.013
|
[8]
|
M. Nowotny, S. A. Gaidamakov, R. J. Crouch, et al., “Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Ca-talysis,” Cell, Vol. 121, No. 7, 2005, pp. 1005-1016.
doi:10.1016/j.cell.2005.04.024
|
[9]
|
J. A. Cowan, T. Ohyama, K. Howard, et al., “Metal-Ion Stoichiometry of the HIV-1 RT Ribonuclease H Domain: Evidence for Two Mutually Exclusive Sites Leads to New Mechanistic Insights on Metal-Mediated Hydrolysis in Nucleic Acid Biochemistry,” Journal of Biological In-organic Chemistry, Vol. 5, No. 1, 2000, pp. 67-74.
doi:10.1007/s007750050009
|
[10]
|
J. Q. Hang, S. Rajendran, Y. L. Yang, et al., “Activity of the Isolated HIV Rnase H Domain and Specific Inhibition by N-Hydroxyimides,” Biochemical and Biophysical Re-search Communications, Vol. 317, No. 2, 2004, pp. 321- 329.
|
[11]
|
K. Pari, G. A. Mueller, E. F. Derose, et al., “Solution Structure of the Rnase H Domain of the HIV-1 Reverse Transcriptase in the Presence of Magnesium,” Biochem, Vol. 42, No. 3, 2003, pp. 639-650.
doi:10.1021/bi0204894
|
[12]
|
K. Katayanagi, M. Okumura and K. Morikawa, “Crystal Structure of Escherichia Coli Rnase HI in Complex with Mg2+ at 2.8 a Resolution: Proof for a Single Mg(2+)-Binding Site,” Proteins, Vol. 17, No. 4, 1993, pp. 337-346.
doi:10.1002/prot.340170402
|
[13]
|
M. Nowotny, S. A. Gaidamakov, R. Ghirlando, et al., “Structure of Human Rnase H1 Complexed with an RNA/DNA Hybrid: Insight into HIV Reverse Transcrip-tion,” Molecular Cell, Vol. 28, No. 2, 2007, pp. 264-276.
doi:10.1016/j.molcel.2007.08.015
|
[14]
|
O. Schatz, F. V. Cromme, F. Grüninger-Leitch, et al., “Point Mutations in Conserved Amino Acid Residues within the C-Terminal Domain of HIV-1 Reverse Tran-scriptase Specifically Repress RNase H Function,” FEBS Letters, Vol. 257, No. 2, 1989, pp. 311-314.
doi:10.1016/0014-5793(89)81559-5
|
[15]
|
S. F. Le Grice, T. Naas, B. Wohigensinger, et al., “Sub-unit-Selective Mutagenesis Indicates Minimal Polymerase Activity in Heterodimer-Associated P51 HIV-1 Reverse Transcriptase,” The EMBO Journal, Vol. 10, No. 12, 1991, pp. 3905-3911.
|
[16]
|
K. Klumpp and T. Mirzadegan, “Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H,” Current Pharmaceutical Design, Vol. 12, No. 15, 2006, pp. 1909- 1922. doi:10.2174/138161206776873653
|
[17]
|
E. Tramontano, “HIV-1 RNase H: Recent Progress in an Exciting, Yet Little Explored, Drug Target,” Mini-Reviews in Medicinal Chemistry, Vol. 6, No. 6, 2006, pp. 727-737.
doi:10.2174/138955706777435733
|
[18]
|
G. M. Clore and A. M. Gronenborn, “Multidimensional Heteronuclear Nuclear Magnetic Resonance of Proteins,” Methods in Enzymology, Vol. 239, 1994, pp. 349-363.
doi:10.1016/S0076-6879(94)39013-4
|
[19]
|
S. Grzesiek and A. Bax, “Amino Acid Type Determination in the Sequential Assignment Procedure of Uniformly 13C/15N-Enriched Proteins,” Journal of Biomolecular NMR, Vol. 3, No. 2, 1993, pp. 185-204.
|
[20]
|
D. Goddard and D. G. Kneller, “SPARKY 3,” University of California, San Francisco, 2000.
|
[21]
|
D. M. Himmel, K. A. Maegley, T. A. Pauly, et al., “Structure of HIV-1 Reverse Transcriptase with the Inhi-bitor Beta-Thujap- licinol Bound at the RNase H Active Site,” Structure, Vol. 17, No. 12, 2009, pp. 1625-1635.
doi:10.1016/j.str.2009.09.016
|
[22]
|
A. Jacobo-Molina, J. Ding, R. G. Nanni, et al., “Crystal Structure of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Complexed with Double-Stranded DNA at 3.0 a Resolution Shows Bent DNA,” Proceedings of the National Academy of Sciences of the USA, Vol. 90, No. 13, 1993, pp. 6320-6324.
|
[23]
|
J. L. Keck and S. Marqusee, “The Putative Substrate Rec-ognition Loop of Escherichia Coli Ribonuclease H Is Not Essential for Activity,” Journal of Biological Chemistry, Vol. 271, No. 33, 1996, pp. 19883-19887.
doi:10.1074/jbc.271.33.19883
|
[24]
|
G. A. Mueller, K. Pari, E. F. Derose, et al., “Backbone Dynamics of the Rnase H Domain of HIV-1 Reverse Transcriptase,” Biochem, Vol. 43, No. 29, 2004, pp. 9332-9342.
|
[25]
|
Y. Oda, H. Nakamura, S. Kanaya, et al., “Binding of Metal Ions to E. coli Rnase HI Observed by 1H-15N He-teronuclear 2D NMR,” Journal of Biomolecular NMR, Vol. 1, No. 3, 1991, pp. 247-255.
doi:10.1007/BF01875518
|
[26]
|
Y. Oda, H. Nakamura and S. Kanaya, “Role of Histidine 124 in the Catalytic Function of Ribonuclease HI from Escherichia coli,” Journal of Biological Chemistry, Vol. 268, No. 1, 1993, pp. 88-92.
|
[27]
|
R. Powers, G. M. Clore, A. Bax, et al., “Secondary Structure of the Ribonuclease H Domain of the Human Immunodeficiency Virus Reverse Transcriptase in Solu-tion Using Three-Dimensional Double and Triple Re-sonance Heteronuclear Magnetic Resonance Spectrosco-py,” Journal of Molecular Biology, Vol. 221, No. 4, 1991, pp. 1081- 1090.
|
[28]
|
R. Powers, G. M. Clore, S. J. Stahl, et al., “Analysis of the Backbone Dynamics of the Ribonuclease H Domain of the Human Immunodeficiency Virus Reverse Tran-scriptase Using 15N Relaxation Measurements,” Biochem, Vol. 31, No. 38, 1992, pp. 9150-9157.
doi:10.1021/bi00153a006
|
[29]
|
D. Chattopadhyay, B. C. Finzel, S. H. Munson, et al., “Crystallographic Analyses of an Active HIV-1 Ribo-nuclease H Domain Show Structural Features That Dis-tinguish It from the Inactive Form,” Acta Crystallogra-phica Section D: Biological Crystallography, Vol. 49, 1993, pp. 423-427. doi:10.1107/S0907444993002409
|
[30]
|
J. F. Davies, Z. Hostomska, J. Hostomsky, et al., “Crystal Structure of the Ribonuclease H Domain of HIV-1 Re-verse Transcriptase,” Science, Vol. 252, No. 5002, 1991, pp. 88-95. doi:10.1126/science.1707186
|
[31]
|
J. J?ger, S. J. Smerdon, J. M. Wang, et al., “Comparison of Three Different Crystal Forms Shows HIV-1 Reverse Transcriptase Displays an Internal Swivel Motion,” Structure, Vol. 2, No. 9, 1994, pp. 869-876.
doi:10.1016/S0969-2126(94)00087-5
|
[32]
|
J. A. Grobler, K. Stillmock, B. Hu, et al., “Diketo Acid Inhibitor Mechanism and HIV-1 Integrase: Implications for Metal Binding in the Active Site of Phosphotransferase Enzymes,” Proc. Natl. Acad. Sci. USA, Vol. 99, No. 10, 2002, pp. 6661-6666.
doi:10.1073/pnas.092056199
|
[33]
|
S. R. Budihas, I. Gorshkova, S. Gaidamakov, et al., “Se-lective Inhibition of HIV-1 Reverse Transcriptase-Asso- ciated Ribonuclease H Activity by Hydroxylated Tropo-lones,” Nucleic Acids Research, Vol. 33, No. 4, 2005, pp. 1249-1256. doi:10.1093/nar/gki268
|